CH CRL (R4)
0.9.0 - Draft
CH CRL (R4)
0.9.0 - Draft
This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions 
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="nkrs-iccc3code"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-iccc3code defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">Ia<a name="nkrs-iccc3code-Ia"> </a></td><td>Lymphoid leukaemias</td></tr><tr><td style="white-space:nowrap">Ib<a name="nkrs-iccc3code-Ib"> </a></td><td>Acute myeloid leukemias</td></tr><tr><td style="white-space:nowrap">Ic<a name="nkrs-iccc3code-Ic"> </a></td><td>Chronic myeloproliferative diseases</td></tr><tr><td style="white-space:nowrap">Id<a name="nkrs-iccc3code-Id"> </a></td><td>Myelodysplastic syndrome and other myeloproliferative diseases</td></tr><tr><td style="white-space:nowrap">Ie<a name="nkrs-iccc3code-Ie"> </a></td><td>Unspecified and other specified leukemias</td></tr><tr><td style="white-space:nowrap">IIa<a name="nkrs-iccc3code-IIa"> </a></td><td>Hodgkin lymphomas</td></tr><tr><td style="white-space:nowrap">IIb<a name="nkrs-iccc3code-IIb"> </a></td><td>Non-Hodgkin lymphomas (except Burkitt lymphoma)</td></tr><tr><td style="white-space:nowrap">IIc<a name="nkrs-iccc3code-IIc"> </a></td><td>Burkitt lymphoma</td></tr><tr><td style="white-space:nowrap">IId<a name="nkrs-iccc3code-IId"> </a></td><td>Miscellaneous lymphoreticular neoplasms</td></tr><tr><td style="white-space:nowrap">IIe<a name="nkrs-iccc3code-IIe"> </a></td><td>Unspecified lymphomas</td></tr><tr><td style="white-space:nowrap">IIIa<a name="nkrs-iccc3code-IIIa"> </a></td><td>Ependymomas and choroid plexus tumor</td></tr><tr><td style="white-space:nowrap">IIIb<a name="nkrs-iccc3code-IIIb"> </a></td><td>Astrocytomas</td></tr><tr><td style="white-space:nowrap">IIIc<a name="nkrs-iccc3code-IIIc"> </a></td><td>Intracranial and intraspinal embryonal tumors</td></tr><tr><td style="white-space:nowrap">IIId<a name="nkrs-iccc3code-IIId"> </a></td><td>Other gliomas</td></tr><tr><td style="white-space:nowrap">IIIe<a name="nkrs-iccc3code-IIIe"> </a></td><td>Other specified intracranial and intraspinal neoplasms</td></tr><tr><td style="white-space:nowrap">IIIf<a name="nkrs-iccc3code-IIIf"> </a></td><td>Unspecified intracranial and intraspinal neoplasms</td></tr><tr><td style="white-space:nowrap">IVa<a name="nkrs-iccc3code-IVa"> </a></td><td>Neuroblastoma and ganglioneuroblastoma</td></tr><tr><td style="white-space:nowrap">IVb<a name="nkrs-iccc3code-IVb"> </a></td><td>Other peripheral nervous cell tumors</td></tr><tr><td style="white-space:nowrap">V<a name="nkrs-iccc3code-V"> </a></td><td>Retinoblastoma</td></tr><tr><td style="white-space:nowrap">VIa<a name="nkrs-iccc3code-VIa"> </a></td><td>Nephroblastoma and other nonepithelial renal tumors</td></tr><tr><td style="white-space:nowrap">VIb<a name="nkrs-iccc3code-VIb"> </a></td><td>Renal carcinomas</td></tr><tr><td style="white-space:nowrap">VIc<a name="nkrs-iccc3code-VIc"> </a></td><td>Unspecified malignant renal tumors</td></tr><tr><td style="white-space:nowrap">VIIa<a name="nkrs-iccc3code-VIIa"> </a></td><td>Hepatoblastoma</td></tr><tr><td style="white-space:nowrap">VIIb<a name="nkrs-iccc3code-VIIb"> </a></td><td>Hepatic carcinomas</td></tr><tr><td style="white-space:nowrap">VIIc<a name="nkrs-iccc3code-VIIc"> </a></td><td>Unspecified malignant hepatic tumors</td></tr><tr><td style="white-space:nowrap">VIIIa<a name="nkrs-iccc3code-VIIIa"> </a></td><td>Osteosarcomas</td></tr><tr><td style="white-space:nowrap">VIIIb<a name="nkrs-iccc3code-VIIIb"> </a></td><td>Chondrosarcomas</td></tr><tr><td style="white-space:nowrap">VIIIc<a name="nkrs-iccc3code-VIIIc"> </a></td><td>Ewing tumor and related sarcomas of bone</td></tr><tr><td style="white-space:nowrap">VIIId<a name="nkrs-iccc3code-VIIId"> </a></td><td>Other specified malignant bone tumors</td></tr><tr><td style="white-space:nowrap">VIIIe<a name="nkrs-iccc3code-VIIIe"> </a></td><td>Unspecified malignant bone tumors</td></tr><tr><td style="white-space:nowrap">IXa<a name="nkrs-iccc3code-IXa"> </a></td><td>Rhabdomyosarcomas</td></tr><tr><td style="white-space:nowrap">IXb<a name="nkrs-iccc3code-IXb"> </a></td><td>Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms</td></tr><tr><td style="white-space:nowrap">IXc<a name="nkrs-iccc3code-IXc"> </a></td><td>Kaposi sarcoma</td></tr><tr><td style="white-space:nowrap">IXd<a name="nkrs-iccc3code-IXd"> </a></td><td>Other specified soft tissue sarcomas</td></tr><tr><td style="white-space:nowrap">IXe<a name="nkrs-iccc3code-IXe"> </a></td><td>Unspecified soft tissue sarcomas</td></tr><tr><td style="white-space:nowrap">Xa<a name="nkrs-iccc3code-Xa"> </a></td><td>Intracranial and intraspinal germ cell tumors</td></tr><tr><td style="white-space:nowrap">Xb<a name="nkrs-iccc3code-Xb"> </a></td><td>Malignant extracranial and extragonadal germ cell tumors</td></tr><tr><td style="white-space:nowrap">Xc<a name="nkrs-iccc3code-Xc"> </a></td><td>Malignant gonadal germ cell tumors</td></tr><tr><td style="white-space:nowrap">Xd<a name="nkrs-iccc3code-Xd"> </a></td><td>Gonadal carcinomas</td></tr><tr><td style="white-space:nowrap">Xe<a name="nkrs-iccc3code-Xe"> </a></td><td>Other and unspecified malignant gonadal tumors</td></tr><tr><td style="white-space:nowrap">XIa<a name="nkrs-iccc3code-XIa"> </a></td><td>Adrenocortical carcinomas</td></tr><tr><td style="white-space:nowrap">XIb<a name="nkrs-iccc3code-XIb"> </a></td><td>Thyroid carcinomas</td></tr><tr><td style="white-space:nowrap">XIc<a name="nkrs-iccc3code-XIc"> </a></td><td>Nasopharyngeal carcinomas</td></tr><tr><td style="white-space:nowrap">XId<a name="nkrs-iccc3code-XId"> </a></td><td>Malignant melanomas</td></tr><tr><td style="white-space:nowrap">XIe<a name="nkrs-iccc3code-XIe"> </a></td><td>Skin carcinomas</td></tr><tr><td style="white-space:nowrap">XIf<a name="nkrs-iccc3code-XIf"> </a></td><td>Other and unspecified carcinomas</td></tr><tr><td style="white-space:nowrap">XIIa<a name="nkrs-iccc3code-XIIa"> </a></td><td>Other specified malignant tumors</td></tr><tr><td style="white-space:nowrap">XIIb<a name="nkrs-iccc3code-XIIb"> </a></td><td>Other unspecified malignant tumours</td></tr><tr><td style="white-space:nowrap">140<a name="nkrs-iccc3code-140"> </a></td><td>Langerhans cell histiocytosis</td></tr><tr><td style="white-space:nowrap">150<a name="nkrs-iccc3code-150"> </a></td><td>Neoplasms of uncertain behaviour or in situ</td></tr></table></div>
</text>
<url value="http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-iccc3code"/>
<version value="0.9.0"/>
<name value="NkrsICCC3Code"/>
<title value="NKRS - ICCC-3 Code"/>
<status value="active"/>
<date value="2022-02-04T14:14:21+01:00"/>
<publisher value="Bundesamt für Gesundheit BAG"/>
<contact>
<name value="Bundesamt für Gesundheit BAG"/>
<telecom>
<system value="url"/>
<value value="https://www.bag.admin.ch/"/>
</telecom>
</contact>
<description
value="This data item records detailed division of the diagnostic group according to the third revision
of the 1996 International Classification of Childhood Cancer (ICCC-3).
**ICCC-3 code (Variable number: 3.9.2)**
in \'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\'
([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf),
[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf),
[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf),
[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf))"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
</coding>
</jurisdiction>
<copyright value="CC-BY-SA-4.0"/>
<caseSensitive value="true"/>
<valueSet value="http://fhir.ch/ig/ch-crl/ValueSet/nkrs-iccc3code"/>
<content value="complete"/>
<count value="50"/>
<concept>
<code value="Ia"/>
<display value="Lymphoid leukaemias"/>
</concept>
<concept>
<code value="Ib"/>
<display value="Acute myeloid leukemias"/>
</concept>
<concept>
<code value="Ic"/>
<display value="Chronic myeloproliferative diseases"/>
</concept>
<concept>
<code value="Id"/>
<display
value="Myelodysplastic syndrome and other myeloproliferative diseases"/>
</concept>
<concept>
<code value="Ie"/>
<display value="Unspecified and other specified leukemias"/>
</concept>
<concept>
<code value="IIa"/>
<display value="Hodgkin lymphomas"/>
</concept>
<concept>
<code value="IIb"/>
<display value="Non-Hodgkin lymphomas (except Burkitt lymphoma)"/>
</concept>
<concept>
<code value="IIc"/>
<display value="Burkitt lymphoma"/>
</concept>
<concept>
<code value="IId"/>
<display value="Miscellaneous lymphoreticular neoplasms"/>
</concept>
<concept>
<code value="IIe"/>
<display value="Unspecified lymphomas"/>
</concept>
<concept>
<code value="IIIa"/>
<display value="Ependymomas and choroid plexus tumor"/>
</concept>
<concept>
<code value="IIIb"/>
<display value="Astrocytomas"/>
</concept>
<concept>
<code value="IIIc"/>
<display value="Intracranial and intraspinal embryonal tumors"/>
</concept>
<concept>
<code value="IIId"/>
<display value="Other gliomas"/>
</concept>
<concept>
<code value="IIIe"/>
<display value="Other specified intracranial and intraspinal neoplasms"/>
</concept>
<concept>
<code value="IIIf"/>
<display value="Unspecified intracranial and intraspinal neoplasms"/>
</concept>
<concept>
<code value="IVa"/>
<display value="Neuroblastoma and ganglioneuroblastoma"/>
</concept>
<concept>
<code value="IVb"/>
<display value="Other peripheral nervous cell tumors"/>
</concept>
<concept>
<code value="V"/>
<display value="Retinoblastoma"/>
</concept>
<concept>
<code value="VIa"/>
<display value="Nephroblastoma and other nonepithelial renal tumors"/>
</concept>
<concept>
<code value="VIb"/>
<display value="Renal carcinomas"/>
</concept>
<concept>
<code value="VIc"/>
<display value="Unspecified malignant renal tumors"/>
</concept>
<concept>
<code value="VIIa"/>
<display value="Hepatoblastoma"/>
</concept>
<concept>
<code value="VIIb"/>
<display value="Hepatic carcinomas"/>
</concept>
<concept>
<code value="VIIc"/>
<display value="Unspecified malignant hepatic tumors"/>
</concept>
<concept>
<code value="VIIIa"/>
<display value="Osteosarcomas"/>
</concept>
<concept>
<code value="VIIIb"/>
<display value="Chondrosarcomas"/>
</concept>
<concept>
<code value="VIIIc"/>
<display value="Ewing tumor and related sarcomas of bone"/>
</concept>
<concept>
<code value="VIIId"/>
<display value="Other specified malignant bone tumors"/>
</concept>
<concept>
<code value="VIIIe"/>
<display value="Unspecified malignant bone tumors"/>
</concept>
<concept>
<code value="IXa"/>
<display value="Rhabdomyosarcomas"/>
</concept>
<concept>
<code value="IXb"/>
<display
value="Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms"/>
</concept>
<concept>
<code value="IXc"/>
<display value="Kaposi sarcoma"/>
</concept>
<concept>
<code value="IXd"/>
<display value="Other specified soft tissue sarcomas"/>
</concept>
<concept>
<code value="IXe"/>
<display value="Unspecified soft tissue sarcomas"/>
</concept>
<concept>
<code value="Xa"/>
<display value="Intracranial and intraspinal germ cell tumors"/>
</concept>
<concept>
<code value="Xb"/>
<display value="Malignant extracranial and extragonadal germ cell tumors"/>
</concept>
<concept>
<code value="Xc"/>
<display value="Malignant gonadal germ cell tumors"/>
</concept>
<concept>
<code value="Xd"/>
<display value="Gonadal carcinomas"/>
</concept>
<concept>
<code value="Xe"/>
<display value="Other and unspecified malignant gonadal tumors"/>
</concept>
<concept>
<code value="XIa"/>
<display value="Adrenocortical carcinomas"/>
</concept>
<concept>
<code value="XIb"/>
<display value="Thyroid carcinomas"/>
</concept>
<concept>
<code value="XIc"/>
<display value="Nasopharyngeal carcinomas"/>
</concept>
<concept>
<code value="XId"/>
<display value="Malignant melanomas"/>
</concept>
<concept>
<code value="XIe"/>
<display value="Skin carcinomas"/>
</concept>
<concept>
<code value="XIf"/>
<display value="Other and unspecified carcinomas"/>
</concept>
<concept>
<code value="XIIa"/>
<display value="Other specified malignant tumors"/>
</concept>
<concept>
<code value="XIIb"/>
<display value="Other unspecified malignant tumours"/>
</concept>
<concept>
<code value="140"/>
<display value="Langerhans cell histiocytosis"/>
</concept>
<concept>
<code value="150"/>
<display value="Neoplasms of uncertain behaviour or in situ"/>
</concept>
</CodeSystem>